JP Morgan 2025: Dexcom shares up 5% after 2025 outlook forecasts $4.6bn in revenue
Buoyed by the recent launch of Stelo and further upcoming CGM launches, Dexcom is anticipating a 14% growth in 2025 over 2024.
14 January 2025
14 January 2025
Buoyed by the recent launch of Stelo and further upcoming CGM launches, Dexcom is anticipating a 14% growth in 2025 over 2024.
NVIDIA starts 2025 by announcing a trio of partnerships and a research collaboration to boost healthcare sector presence.
Guardant’s preliminary full-year revenue estimate for 2024 indicates a 31% increase over 2023.
The Truveta Genome Project aims to establish the world’s largest and most diverse database of genetic information.
The FDA has approved MEL 90 for the eye treatment indications of myopia, hyperopia, and mixed astigmatism.
The Labour government’s blueprint for AI driven growth and productivity has been welcomed by the UK tech industry. But whether the recommendations will be enacted remains to be seen.
Cancer Research UK provided the funding for the study, which saw participation from UCL, UCLH and Francis Crick Institute.
The investment was spearheaded by Redmile Group, with contributions from current and new investors.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.